PTC Therapeutics Market Sentiment

PTC Therapeutics Inc

PTCTNASDAQ

Trade with Public

$71.70

-0.27-0.38%

At close: Aug 14, 5:00 PM EST

$71.70

N/A

After Hours: Aug 14, 4:00 PM EST

M&A: Sangamo Therapeutics announced it will sell assets to PTC Therapeutics (PTCT) on Wednesday, August 12, 2026

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

PTC Therapeutics Market Sentiment

Market sentiment signals for PTC Therapeutics (PTCT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 17.2% short float

Options Flow▲ 0.01 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

19 analysts

Options Flow (P/C)

0.01

More calls — Bullish

204 calls · 2 puts

Avg Consensus PT

$84

+16.9%

Highest Price Target

$130

+81.3%

Cantor Fitzgerald

Lowest Price Target

$45

-37.2%

Citigroup

Short Interest

17.2%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 14, 2026	Barclays	Eliana Merle—	+70.2%	$120 → $122	Maintained	Overweight
Aug 13, 2026	Wells Fargo	Benjamin Burnett—	+52.0%	$106 → $109	Maintained	Overweight
Jul 31, 2026	Morgan Stanley	Jeffrey Hung—	+45.0%	$93 → $104	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Benjamin Burnett—	+47.8%	$93 → $106	Maintained	Overweight
Jul 20, 2026	Wells Fargo	Benjamin Burnett—	+29.7%	$95 → $93	Maintained	Overweight
Jul 16, 2026	Cantor Fitzgerald	Kristen Kluska—	+81.3%	$124 → $130	Maintained	Overweight
Jul 7, 2026	RBC Capital	Brian Abrahams—	+18.5%	$82 → $85	Maintained	Sector Perform
Jun 9, 2026	Citigroup	Geoff Meacham—	+50.6%	$75 → $108	Assumes	Neutral→Buy
May 27, 2026	Jefferies	Faisal Khurshid—	+18.5%	$76 → $85	Upgrade	Hold→Buy
May 8, 2026	TD Cowen	Joseph Thome—	+25.5%	$75 → $90	Upgrade	Hold→Buy
May 8, 2026	RBC Capital	Brian Abrahams—	+14.4%	$81 → $82	Maintained	Sector Perform
May 8, 2026	Wells Fargo	Benjamin Burnett—	+32.5%	$86 → $95	Maintained	Overweight
Mar 30, 2026	Jefferies	Faisal Khurshid—	+6.0%	$91 → $76	Downgrade	Buy→Hold
Feb 23, 2026	Morgan Stanley	Jeffrey Hung—	+28.3%	$90 → $92	Maintained	Overweight
Feb 20, 2026	Wells Fargo	Benjamin Burnett—	+19.9%	$93 → $86	Maintained	Overweight
Feb 20, 2026	RBC Capital	Brian Abrahams—	+14.4%	$87 → $82	Maintained	Sector Perform
Feb 20, 2026	B of A Securities	Tazeen Ahmad—	+29.7%	$97 → $93	Maintained	Buy
Jan 28, 2026	Barclays	Eliana Merle—	+66.0%	$68 → $119	Upgrade	Equal-Weight→Overweight
Dec 1, 2025	RBC Capital	Brian Abrahams—	+26.9%	$82 → $91	Downgrade	Outperform→Sector Perform
Nov 6, 2025	Barclays	Gena Wang—	-5.2%	$46 → $68	Maintained	Equal-Weight
Nov 5, 2025	Citigroup	Geoff Meacham—	+4.6%	$50 → $75	Maintained	Neutral
Nov 5, 2025	TD Cowen	Joseph Thome—	-12.1%	$50 → $63	Maintained	Hold
Nov 5, 2025	RBC Capital	Brian Abrahams—	+14.4%	$70 → $82	Maintained	Outperform
Nov 5, 2025	Goldman Sachs	Paul Choi—	-30.3%	$44 → $50	Maintained	Sell
Nov 5, 2025	Wells Fargo	Benjamin Burnett—	+29.7%	$73 → $93	Maintained	Overweight